Compare safety reporting timelines
Separate EU and US post-marketing rules from clinical-trial rules.
See the prompt
Compare EU and US expedited reporting requirements for post-marketing individual case safety reports for human medicines. Explain how seriousness, expectedness, case origin, and minimum case information affect reporting and the start of the clock. Distinguish these from clinical-trial reporting and cite current official guidance.